Status:
COMPLETED
Improving Albuminuria Screening Compliance Using a Smartphone Urinalysis Kit
Lead Sponsor:
Geisinger Clinic
Collaborating Sponsors:
National Kidney Foundation, United States
Healthy.io Ltd.
Conditions:
Albuminuria
Chronic Kidney Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will test the effectiveness of mailed, smartphone urinalysis kits to improve albuminuria screening compliance and detection of albuminuria.
Detailed Description
This proposal will examine the effect of mailed, smartphone urinalysis kits to improve albuminuria screening compliance and detection of albuminuria. The investigators will randomize 1,000 non-diabeti...
Eligibility Criteria
Inclusion
- 18 and older
- Hypertension
- Last outpatient BP ≥ 130/80 mmHg
- Active MyGeisinger users with a listed mobile phone number
- Has a Geisinger PCP and followed by the Care Gaps team
- No prior urine albuminuria test (urine dipstick, albumin/creatinine ratio, protein/creatinine ratio)
Exclusion
- History of diabetes
- Receiving dialysis
- History of kidney transplant
- eGFR \< 15 ml/min/1.73m2
- Principal investigator or PCP discretion (i.e. concerns about safety, compliance)
Key Trial Info
Start Date :
March 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 19 2018
Estimated Enrollment :
999 Patients enrolled
Trial Details
Trial ID
NCT03470701
Start Date
March 19 2018
End Date
June 19 2018
Last Update
July 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger Health System
Danville, Pennsylvania, United States, 17821